Fig. 3
From: Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis
Forest plot and pooled analysis of hazard ratio for overall survival (OS) (a), recurrence-free survival (RFS) (b), and metastasis-free survival (MFS) (c) in RPS patients with adjuvant chemotherapy